Recurrence score testing does not appear to benefit patients with grade I PR positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Recurrence score testing does not appear to benefit patients with grade I PR positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs

【24h】

Recurrence score testing does not appear to benefit patients with grade I PR positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs

机译：复发评分试验似乎没有患有I级PR阳性乳腺癌的患者：一个消除过度处理和降低测试成本的机会

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Recurrence score testing does not appear to benefit patients with grade I PR positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：复发评分试验似乎没有患有I级PR阳性乳腺癌的患者：一个消除过度处理和降低测试成本的机会
2. Apparent diffusion coefficient in estrogen receptor‐positive and lymph node‐negative invasive breast cancers at 3.0T DW‐MRI: A potential predictor for an oncotype Dx test recurrence score [J] . Thakur Sunitha B., Durando Manuela, Milans Soledad, Journal of magnetic resonance imaging: JMRI . 2018,第2期

机译：3.0T DW-MRI的雌激素受体阳性和淋巴结阴性侵袭性乳腺癌的表观扩散系数：腹型DX测试复发评分的潜在预测因子
3. Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study [J] . Zeng Yinduo, Li Qian, Qin Tao, Anticancer Research: International Journal of Cancer Research and Treatment . 2017,第8期

机译：21-基因复发评分试验对激素受体阳性早期乳腺癌选择辅助化疗的影响：一项前瞻性研究
4. Survival Analysis of Colorectal Cancer Patients with Tumor Recurrence Using Global Score Test Methodology [C] . Zakiyah Zain, Nazrina Aziz, Yuhaniz Ahmad, International Conference on Quantitative Sciences and Its Applications . 2014

机译：使用全球评分试验方法肿瘤复发性结直肠癌患者的存活分析
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype DX test recurrence scores [O] . Sunitha B. Thakur, Manuela Durando, Soledad Milans, -1

机译：在3.0T DW-MRI时雌激素受体阳性和淋巴结阴性浸润性乳腺癌中的表观扩散系数：肿瘤型DX测试复发评分的潜在预测因子
7. Chemotherapy is one of the therapies for cancer patients that cause some side effects, one of them is nausea and vomiting. Nausea and vomiting are still felt by patients even though they take antiemetics. Nausea dan vomiting can cause fluid and electrolyte imbalance. The aim of this study was to analysis the effect of combination acupressure wristband and antiemetic among chemotherapy induced nausea vomiting (CINV) on breast cancer patients. This research used quasi experimental research method, with a pre-post test with the control group. The sampling techniques was consecutive sampling with 25 respondents both in intervention group and control group. In the intervention group had received an acupressure wristband. CINV measured on the second day until fourth day after chemotherapy. Nausea and vomiting score were measured twice a day by a telemonitoring methode by Rhodes Index Nausea, Vomiting and Retching (INVR) questionaire. Data were analyzed by paired t-test, independent t-test, Wilcoxon test and Mann Whitney. The result of this study showed that acupressure wristband significantly reduce the chemotherapy induced nausea and vomit (p value = 0.000). The use of acupressure wristband combined with antiemetic therapy can significantly decrease chemotherapy induced nausea and vomiting in breast cancer patients. Acupressure wristband recommended for consideration nursing intervention in treating breast cancer patients who experience nausea and vomiting. [O] . Endah Fatma 2018

机译：化疗是癌症患者的疗法之一，导致一些副作用，其中一个是恶心和呕吐。患者仍然感受到恶心和呕吐，即使他们服用助性学。恶心丹呕吐会导致液体和电解质不平衡。本研究的目的是分析组合组合腕带和抑制在乳腺癌患者中的诱导恶心呕吐（CINV）的影响。本研究使用了准实验研究方法，用对照组进行了预先测试。采样技术是在干预组和对照组中进行25名受访者的连续抽样。在干预组中，收到了一名腕带。 Cinv在化疗后第四天测量。通过罗得岛指数恶心，呕吐和转换（INVR）问卷，每天测量恶心和呕吐分数。通过配对的T检验，独立的T检验，Wilcoxon测试和Mann Whitney分析数据。该研究的结果表明，Acuruce腕带显着降低化疗诱导的恶心和呕吐物（P值= 0.000）。使用Acu压抑腕带与止吐疗法相结合，可以显着降低乳腺癌患者诱导的恶心和呕吐。 Acu压痕腕带推荐用于治疗体验恶心和呕吐的乳腺癌患者的护理干预。

Recurrence score testing does not appear to benefit patients with grade I PR positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs

著录项

相似文献

相关主题

期刊订阅